Dr. Young is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2428 Castillo St
Ste D
Santa Barbara, CA 93105Phone+1 805-682-1560
Education & Training
- University of Alabama Medical CenterResidency, Internal Medicine, 2017
- LA County USC Medical Center1974 - 1976
- Henry Ford Health/Henry Ford HospitalInternship, Internal Medicine, 1973 - 1974
- University of Southern California/LACUSC Medical CenterInternship, Internal Medicine, 1972 - 1973
- Keck School of Medicine of the University of Southern CaliforniaClass of 1972
- University of MichiganB.S, Zoology, 1964 - 1968
Certifications & Licensure
- MI State Medical License Current
- CA State Medical License 1974 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Excellence in Teaching Award Residents Santa Barbara Cottage Hospital, 1981, 1982
- Alpha Omega Alpha (as a Junior) University of Southern California School of Medicine, 1972
- Phi Kappa Phi (All University) University of Southern California, 1972
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsBiphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelia...Jia Wang, James Sinnett-Smith, Jan V. Stevens, Steven H. Young, Enrique Rozengurt
The Journal of Biological Chemistry. 2016-08-19 - 24 citationsProstaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.Hui-Hua Chang, Steven H. Young, James Sinnett-Smith, Caroline Ei Ne Chou, Aune Moro
American Journal of Physiology. Cell Physiology. 2015-11-15 - 78 citationsDual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2Heloisa P. Soares, Ming Ming, Michelle Mellon, Steven H. Young, Liang Han
Molecular Cancer Therapeutics. 2015-02-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: